Jasper Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Jasper Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q3 2024.
  • Jasper Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 15M shares, a 46.6% increase year-over-year.
  • Jasper Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 10.4M shares, a 186% increase from 2022.
  • Jasper Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3.65M shares, a 68% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 15M +4.77M +46.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 15M +4.07M +37.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 13.3M +4.55M +51.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 10.4M +6.79M +186% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 10.2M -26.3M -72% Sep 30, 2023 10-Q 2024-11-07
Q3 2023 11M -25.6M -70% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 10.9M -25.5M -70% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 8.79M -27.5M -75.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 3.65M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 36.6M +31.6M +636% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 36.4M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 36.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 4.97M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.